<p>Artivion, Inc.（NYSE：AORT - 获取免费报告）董事 Anthony B. Semedo 在周二，8 月 13 日进行了一笔交易，卖出了公司的 9,709 股股票。这些股票的平均价格为 24.99 美元，总交易额为 242,627.91 美元。交易完成后，该董事现持有公司的 34,159 股股票，价值 853,633.41 美元。该交易已在提交给美国证券交易委员会（SEC）的文件中披露，文件链接可在此处查看。</p>
<h2>Artivion 股价表现</h2>
<p>AORT 股票周四交易上涨 1.21 美元，达到 25.72 美元。该公司股票的交易量为 87,208 股，相比平均交易量 226,466 股。该公司的 50 天移动平均价格为 25.45 美元，200 天移动平均价格为 22.28 美元。Artivion, Inc.一年内最低价为 12.16 美元，最高价为 29.24 美元。该公司的市值为 10.7 亿美元，市盈率为-102.13，β系数为 1.75。该公司的速动比率为 4.26，流动比率为 6.04，负债权益比率为 1.07。</p>
<h2>机构投资者对 Artivion 的看法</h2>
<p>对冲基金和其他机构投资者最近对该公司的持股进行了调整。First Eagle Investment Management LLC 在第一季度增持了 Artivion 股票，持股增长了 8.1%。First Eagle Investment Management LLC 现在持有该公司价值 12,066,000 美元的 570,242 股股票，上季度增持了 42,705 股。Wasatch Advisors LP 在第一季度增加了对 Artivion 的持股，持股增长了 108.8%。Wasatch Advisors LP 现在持有该公司价值 22,928,000 美元的 1,083,568 股股票，上季度增持了 564,549 股。Vanguard Group Inc.在第一季度增持了 Artivion 的持股，持股增长了 1.3%。Vanguard Group Inc.现在持有该公司价值 56,388,000 美元的 2,664,855 股股票，上季度增持了 33,982 股。Tidal Investments LLC 在第一季度新建了对 Artivion 的持股，价值 257,000 美元。最后，Allspring Global Investments Holdings LLC 在第一季度增加了对 Artivion 的持股，持股增长了 291.3%。Allspring Global Investments Holdings LLC 现在持有该公司价值 118,000 美元的 5,580 股股票，上季度增持了 4,154 股。对冲基金和其他机构投资者持有该公司的股份的比例为 86.37%。</p>
<h2>分析师评级变动</h2>
<p>一些分析师最近对 AORT 股票发表了评论。Lake Street Capital 将 Artivion 的目标股价从 28.00 美元提高到 30.00 美元，并在 7 月 2 日的研究报告中给予该公司 “买入” 评级。Needham &amp; Company LLC 在 8 月 9 日的报告中重申了 “买入” 评级，并设定了 30.00 美元的目标股价。Stifel Nicolaus 将 Artivion 的目标股价从 25.00 美元提高到 28.00 美元，并在 8 月 9 日的研究报告中给予该公司 “买入” 评级。最后，Oppenheimer 将 Artivion 的目标股价从 25.00 美元提高到 30.00 美元，并在 8 月 9 日的报告中给予该公司 “表现优异” 评级。</p>
<p><strong>查看我们关于 Artivion 的最新股票报告</strong></p>
<h2>关于 Artivion（获取免费报告）</h2>
<p>Artivion, Inc.在全球范围内制造、加工和分销医疗器械和可植入人体组织。该公司提供 BioGlue，这是一种由牛血蛋白和交联蛋白剂组成的聚合物，用于心脏、血管、神经和肺部手术；心脏保存服务；PhotoFix，一种牛心包膜贴片；以及包括 E-vita Open Plus 和 E-vita Open Neo 在内的主动脉弓支架。</p>
<h2>精选文章</h2>
<ul>
<li>我们喜欢的五支股票胜过 Artivion</li>
<li>投资高市盈率成长股</li>
<li>迈克尔·伯里的阿里巴巴赌注及更广泛的市场影响</li>
<li>电话会议和个人投资者</li>
<li>杰夫·布朗的 Exegesis 人工智能股票推荐</li>
<li>如何投资生物科技股</li>
<li>沃伦·巴菲特的赌注：为什么伯克希尔哈撒韦买入了 Ulta 股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ"/></p>
<p><em>此即时新闻警报由 MarketBeat 的叙事科技和来自 MarketBeat 的金融数据生成，以向读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 2024 年 7882 美元刺激支付是什么？（来自 Angel Publishing）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTgy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTgy"/></p>
<h2>您现在是否应该投资 1,000 美元购买 Artivion 股票？</h2>
<p>在考虑购买 Artivion 股票之前，您可能需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街评级最高、表现最佳的研究分析师以及他们向客户推荐的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户在更广泛市场注意之前现在购买的股票...而 Artivion 并不在这份名单上。</p>
<p>尽管 Artivion 目前在分析师中有 “买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
<p>查看这五支股票</p>

AORT

<p>Artivion, Inc.（NYSE：AORT）董事安东尼·B·塞梅多（Anthony B. Semedo）于 8 月 13 日以平均价格 0.99 美元出售了 9,709 股股票，总价为 9,627.91 美元。交易后，他持有 34,159 股股票，价值约 33,633.41 美元。美国证券交易委员会（SEC）的申报文件披露了这笔交易。该股最近交易价格为 0.72 美元，市值为 0.07 亿美元。分析师已经上调了他们的目标价格，大多数评级为 “买入”。机构投资者持有 86.37% 的股份，上季度 First Eagle Investment Management 和 Wasatch Advisors 的持股大幅增加</p>

<p>Artivion, Inc. (NYSE:AORT - Get Free Report) Director Anthony B. Semedo sold 9,709 shares of the firm's stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $24.99, for a total transaction of $242,627.91. Following the completion of the sale, the director now owns 34,159 shares in the company, valued at $853,633.41. The transaction was disclosed in a document filed with the SEC, which is available at this link.</p>
<div class="lb-trans"><p>Artivion, Inc.（NYSE：AORT - 获取免费报告）董事 Anthony B. Semedo 在周二，8 月 13 日进行了一笔交易，卖出了公司的 9,709 股股票。这些股票的平均价格为 24.99 美元，总交易额为 242,627.91 美元。交易完成后，该董事现持有公司的 34,159 股股票，价值 853,633.41 美元。该交易已在提交给美国证券交易委员会（SEC）的文件中披露，文件链接可在此处查看。</p>
</div><h2>Artivion Price Performance</h2>
<div class="lb-trans"><h2>Artivion 股价表现</h2>
</div><p>AORT stock traded up $1.21 during trading on Thursday, reaching $25.72. The company's stock had a trading volume of 87,208 shares, compared to its average volume of 226,466. The company's fifty day moving average is $25.45 and its 200-day moving average is $22.28. Artivion, Inc. has a 1 year low of $12.16 and a 1 year high of $29.24. The company has a market capitalization of $1.07 billion, a P/E ratio of -102.13 and a beta of 1.75. The company has a quick ratio of 4.26, a current ratio of 6.04 and a debt-to-equity ratio of 1.07.</p>
<div class="lb-trans"><p>AORT 股票周四交易上涨 1.21 美元，达到 25.72 美元。该公司股票的交易量为 87,208 股，相比平均交易量 226,466 股。该公司的 50 天移动平均价格为 25.45 美元，200 天移动平均价格为 22.28 美元。Artivion, Inc.一年内最低价为 12.16 美元，最高价为 29.24 美元。该公司的市值为 10.7 亿美元，市盈率为-102.13，β系数为 1.75。该公司的速动比率为 4.26，流动比率为 6.04，负债权益比率为 1.07。</p>
</div><h2>Institutional Investors Weigh In On Artivion</h2>
<div class="lb-trans"><h2>机构投资者对 Artivion 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the company. First Eagle Investment Management LLC grew its holdings in shares of Artivion by 8.1% during the first quarter. First Eagle Investment Management LLC now owns 570,242 shares of the company's stock valued at $12,066,000 after buying an additional 42,705 shares during the last quarter. Wasatch Advisors LP increased its position in shares of Artivion by 108.8% in the first quarter. Wasatch Advisors LP now owns 1,083,568 shares of the company's stock valued at $22,928,000 after buying an additional 564,549 shares in the last quarter. Vanguard Group Inc. lifted its stake in Artivion by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 2,664,855 shares of the company's stock valued at $56,388,000 after buying an additional 33,982 shares in the last quarter. Tidal Investments LLC acquired a new stake in Artivion during the 1st quarter worth $257,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Artivion by 291.3% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 5,580 shares of the company's stock worth $118,000 after purchasing an additional 4,154 shares during the last quarter. Hedge funds and other institutional investors own 86.37% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近对该公司的持股进行了调整。First Eagle Investment Management LLC 在第一季度增持了 Artivion 股票，持股增长了 8.1%。First Eagle Investment Management LLC 现在持有该公司价值 12,066,000 美元的 570,242 股股票，上季度增持了 42,705 股。Wasatch Advisors LP 在第一季度增加了对 Artivion 的持股，持股增长了 108.8%。Wasatch Advisors LP 现在持有该公司价值 22,928,000 美元的 1,083,568 股股票，上季度增持了 564,549 股。Vanguard Group Inc.在第一季度增持了 Artivion 的持股，持股增长了 1.3%。Vanguard Group Inc.现在持有该公司价值 56,388,000 美元的 2,664,855 股股票，上季度增持了 33,982 股。Tidal Investments LLC 在第一季度新建了对 Artivion 的持股，价值 257,000 美元。最后，Allspring Global Investments Holdings LLC 在第一季度增加了对 Artivion 的持股，持股增长了 291.3%。Allspring Global Investments Holdings LLC 现在持有该公司价值 118,000 美元的 5,580 股股票，上季度增持了 4,154 股。对冲基金和其他机构投资者持有该公司的股份的比例为 86.37%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of analysts recently commented on AORT shares. Lake Street Capital boosted their target price on Artivion from $28.00 to $30.00 and gave the company a &#34;buy&#34; rating in a research report on Tuesday, July 2nd. Needham &amp; Company LLC reaffirmed a &#34;buy&#34; rating and set a $30.00 target price on shares of Artivion in a report on Friday, August 9th. Stifel Nicolaus lifted their target price on shares of Artivion from $25.00 to $28.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, August 9th. Finally, Oppenheimer increased their target price on shares of Artivion from $25.00 to $30.00 and gave the company an &#34;outperform&#34; rating in a report on Friday, August 9th.</p>
<div class="lb-trans"><p>一些分析师最近对 AORT 股票发表了评论。Lake Street Capital 将 Artivion 的目标股价从 28.00 美元提高到 30.00 美元，并在 7 月 2 日的研究报告中给予该公司 “买入” 评级。Needham &amp; Company LLC 在 8 月 9 日的报告中重申了 “买入” 评级，并设定了 30.00 美元的目标股价。Stifel Nicolaus 将 Artivion 的目标股价从 25.00 美元提高到 28.00 美元，并在 8 月 9 日的研究报告中给予该公司 “买入” 评级。最后，Oppenheimer 将 Artivion 的目标股价从 25.00 美元提高到 30.00 美元，并在 8 月 9 日的报告中给予该公司 “表现优异” 评级。</p>
</div><p><strong>View Our Latest Stock Report on Artivion</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Artivion 的最新股票报告</strong></p>
</div><h2>About Artivion (Get Free Report)</h2>
<div class="lb-trans"><h2>关于 Artivion（获取免费报告）</h2>
</div><p>Artivion, Inc manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo.</p>
<div class="lb-trans"><p>Artivion, Inc.在全球范围内制造、加工和分销医疗器械和可植入人体组织。该公司提供 BioGlue，这是一种由牛血蛋白和交联蛋白剂组成的聚合物，用于心脏、血管、神经和肺部手术；心脏保存服务；PhotoFix，一种牛心包膜贴片；以及包括 E-vita Open Plus 和 E-vita Open Neo 在内的主动脉弓支架。</p>
</div><h2>Featured Articles</h2>
<ul>
<li>Five stocks we like better than Artivion</li>
<li>Investing in the High PE Growth Stocks</li>
<li>Michael Burry's Alibaba Bet and the Broader Market Implications</li>
<li>Conference Calls and Individual Investors</li>
<li>Jeff Brown's Exegesis AI Stock Picks</li>
<li>How to Invest in Biotech Stocks</li>
<li>Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock</li>
</ul>
<div class="lb-trans"><h2>精选文章</h2>
<ul>
<li>我们喜欢的五支股票胜过 Artivion</li>
<li>投资高市盈率成长股</li>
<li>迈克尔·伯里的阿里巴巴赌注及更广泛的市场影响</li>
<li>电话会议和个人投资者</li>
<li>杰夫·布朗的 Exegesis 人工智能股票推荐</li>
<li>如何投资生物科技股</li>
<li>沃伦·巴菲特的赌注：为什么伯克希尔哈撒韦买入了 Ulta 股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=AORT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由 MarketBeat 的叙事科技和来自 MarketBeat 的金融数据生成，以向读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ What Is the $7,882 Stimulus Payment 2024? (From Angel Publishing)(Ad)</p>
<div class="lb-trans"><p>→ 2024 年 7882 美元刺激支付是什么？（来自 Angel Publishing）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTgy" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9182&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Artivion right now?</h2>
<div class="lb-trans"><h2>您现在是否应该投资 1,000 美元购买 Artivion 股票？</h2>
</div><p>Before you consider Artivion, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑购买 Artivion 股票之前，您可能需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Artivion wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街评级最高、表现最佳的研究分析师以及他们向客户推荐的股票。MarketBeat 已确定了五支顶级分析师悄悄告诉客户在更广泛市场注意之前现在购买的股票...而 Artivion 并不在这份名单上。</p>
</div><p>While Artivion currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Artivion 目前在分析师中有 “买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五支股票</p>
</div>

Artivion 公司（纽约证券交易所代码：AORT）董事 Anthony B. Semedo 出售了 9,709 股股票